ClinicalTrials.Veeva

Menu
H

Heart Institute of East Texas | Lufkin, TX

Research site
(Unclaimed)

Site insights

Top conditions

Top treatments

Inclisiran
sodium

Curious how this site stacks up to its peers?

Data sourced from clinicaltrials.gov

Work at this site?

CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.

Learn more and claim site

Active trials

1 of 3 total trials

Inclisiran Versus Placebo for the Prevention of Major Adverse Cardiovascular and Limb Events in Patients Undergoing Percutaneous Coronary Intervention or Peripheral Endovascular Intervention (V-INTERVENTION)

V-INTERVENTION will evaluate the effectiveness of inclisiran in preventing major cardiovascular and limb events in patients receiving percutaneous co...

Enrolling
Peripheral Endovascular Intervention
Percutaneous Coronary Intervention
Drug: Normal Saline (Placebo)
Drug: Inclisiran sodium 300 mg (equivalent to 284 mg inclisiran) in 1.5 mL

Trial sponsors

Boston Scientific logo
Duke University logo

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems